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Although computed tomography (CT) of the thorax has been compared to plain chest radiography and 
bronchography for demonstration of central bronchiectasis (CB) in allergic bronchopulmonary aspergil- 
losis (ABPA), the CT presentation of the disease is yet to be highlighted. With this in view, the CT 
appearances in 23 patients with ABPA were evaluated. The scans were assessed for bronchial, 
parenchymal and pleural abnormalities. 
Central bronchiectasis was identified in all patients, involving 114 (85%) of the 134 lobes and 210 
(52%) of the 406 segments studied. Other bronchial abnormalities such as dilated and totally occluded 
bronchi (11 patients), air-fluid levels within dilated bronchi (five patients), bronchial wall thickening (10 
patients) and parallel-line shadows (seven patients) were also observed. 
Parenchymal abnormalities, which had a predilection for upper lobes, included consolidation in 10 
(43%) patients, collapse in four (17%) patients and parenchymal scarring in 19 (83%) patients. A total of 
six cavities were seen in three (13%) patients, and an emphysematous bullae was detected in one (4%) 
patient. The pleura was involved in 10 (43%) patients. Ipsilateral pleural effusion with collapse was 
observed in one patient, while in nine other patients, parenchymal lesions extended up to the pleura. 
Concomitant allergic Aspergillus sinusitis (AAS) was also detected in three (13%) of the 23 patients. 
Computed tomography of the thorax in patients with ABPA provides a sensitive method for the 
assessment of bronchial, parenchymal and pleural abnormalities, and should constitute a part of the 
diagnostic work of the disease. 
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Introduction 
Allergic bronchopulmonary aspergillosis 
(ABPA) is not uncommon in India (1). As it is a 
potentially destructive lung disease, an early 
diagnosis is essential to prevent the development 
of end-stage lung fibrosis. Since its first descrip- 
tion by Hinson et aZ. in 1952 (2), radiological 
techniques have been crucial to the diagnosis of 
the disease. Not only do imaging techniques help 
to establish the diagnosis, but also help to moni- 
tor the progress of the disease. 
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Central/proximal bronchiectasis (CB) with 
normal peripheral bronchi, a pathognomonic 
feature of ABPA, was first described by 
Scadding (3). Demonstration of CB is consid- 
ered a sine qua uwz for the diagnosis of the 
disease (4), for which bronchography was 
regarded as a gold standard (5). However, com- 
puted tomography (CT) of the thorax is now 
accepted as an effective alternative in the diag- 
nosis of bronchiectasis (6-8). Recently, the 
authors have shown that CT in comparison to 
bronchography, a procedure thought to be 
unsafe in asthma, has a sensitivity of 83% and 
a specificity of 92% in detecting CB in patients 
with ABPA (9), and could thus be the 
investigation of choice. Computed tomogra- 
phic scan also enabled rapid and safe estab- 
lishment of the diagnosis in children with 
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TABLE 1. Patient characteristics 
Duration Peripheral Serum 
of Stage on blood IgE levels Cutaneous reactivity Pulmon- 
Subject illness presen- eosinophilia Serum (IU ml- ‘) w 
no. Agelsex (34 tation (cells mm ~ ‘) precipitins (N=O-100) Type I Type III infiltrates 
1 26/M 7 III 3050 + 810 + + + 
2 35/F 28 V 1938 -!- 210 + + + 
3 16/M 4 III 1444 + 610 + + + 
4 32/F 4 III 378 + 540 + + + 
5 55/M 45 II 258 - 580 + + + 
6 45/M 10 III 267 + 680 + + + 
7 32/F 6 II 528 + 120 + + + 
8 28/M 2 III 784 + 800 + + + 
9 48/M 47 III 920 + 670 + + + 
10 37/M 32 III 2848 - 430 + + + 
11 13/M 3 III 1380 + 480 + + + 
12 25/M 5 I 1630 + 780 + + + 
13 50/F 1.5 III 4140 - 540 + + + 
14 50/F 12 IV 1368 + 80 + - + 
15 54/M 11 III 2624 + 410 + -t + 
16 39/M 18 III 1664 - 480 + + + 
17 42/M 7 III 1690 - 250 + + 
18 37/F 8 II 1446 + 100 + + + 
19 421M 11 III 1162 + 400 + + + 
20 11/M 1 I 1440 + 560 + + + 
21 19/F 6 III 1205 + 490 + + + 
22 38/F 35 III 1116 + 540 + + + 
23 29/F 5 III 1504 + 610 + + + 
ABPA who presented with acute severe asthma 
(10). 
The few CT studies on ABPA available so far 
have focused their attention on detection of CB 
on CT as compared to plain chest radiography 
(5,11,12). However, the CT presentation of 
ABPA is yet to be highlighted. With this in view, 
the spectrum of CT appearances in 23 patients 
with ABPA is presented. 
Methods 
PATIENTS 
The study comprised 23 patients (Table 1) who 
were considered to have ABPA in view of the 
following criteria: (1) history of asthma; 
(2) peripheral blood eosinophilia; (3) transient 
pulmonary infiltrates; (4) presence of Type I 
cutaneous reactivity to aspergillin, with or 
without Type III reaction; (5) demonstration of 
serum precipitins against Aspergillus species; and 
(6) elevated total serum immunoglobulin E (IgE) 
levels. 
The study population consisted of 14 males 
and nine females with a mean age of 35 years 
(range 11-55 years). The mean duration of ill- 
ness was 13.5 years (range 147 years). All of the 
23 patients had history of asthma, transient 
pulmonary infiltrates, type I skin reaction to 
aspergillin and elevated serum IgE levels. Periph- 
eral blood eosinophilia (>500 cells mm - 3, was 
present in 20 (87%) of the 23 patients, and serum 
precipitins were positive in 18 (78%) patients. 
The patients, at the time of presentation, were 
staged (4) according to their clinical, radiological 
and immunological status as follows: Stage I 
(Acute), n = 2; Stage II (Remission), n=3; 
Stage III (Exacerbation), y1= 16; Stage IV 
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(Steroid-dependent asthma), n= 1; and Stage V 
(End-stage fibrosis), n= 1. Three (13%) patients 
also had concomitant allergic Aspergillus sinusi- 
tis (AAS) as assessed by biopsy. Of the 23 
patients, 19 (83%) patients had received anti- 
tuberculous therapy before presentation. 
COMPUTED TOMOGRAPHY 
Non-contrast CT of the thorax was performed 
on a Somatom-DRH CT scanner (Siemens 
Erlangen, Germany), with a 512 matrix size. 
Computed tomographic scans were obtained at 
125 kV, 210 mA, with a scan time of 3-5 s in 
the supine position at full end-inspiration from 
lung apex to base with &mm contiguous slices. 
Supplemental 4-mm contiguous slices were 
taken in areas where bronchi were not sharply 
visualized on 8-mm slices. These areas were 
mostly presented in the region of anterior and 
posterior segmental bronchi of the upper lobes, 
medial and lateral segmental bronchi of the 
middle lobes, and apical-basal segmental bron- 
chus of the lower lobes, as these bronchi course 
horizontally and may not be clearly visualized 
on &mm slices due to partial volume-averaging 
effect. The scans were read in a random and 
blinded manner by a team comprising both 
radiologists and pulmonologists, and con- 
clusions were reached by consensus. The scans 
were analysed at lobar as well as segmental 
level. Individual bronchopulmonary segments 
were identified by the anatomical division of 
the appropriate lobar bronchus, and its rela- 
tionship with the major and minor fissures (13). 
All scans were assessed for radiological 
abnormalities and were categorized as follows: 
(1) Bronchial abnormalities in the form of (i) 
‘string of pearls’ appearances, (ii) ‘signet ring’ 
appearances, (iii) beaded tubular opacities, (iv) 
bronchial wall thickening, (v) parallel line opaci- 
ties, or (vi) air-fluid level within the bronchi. The 
criteria used to define these appearances were as 
described by Naidich et al. (14). The distance of 
bronchiectasis from the hilum was ascertained, 
and it was deemed to be central when confined to 
the medial two-thirds of the lung. 
(2) Parenchymal abnormalities which 
included consolidation - lobar, segmental or 
patchy-cavitation, loss of volume due to col- 
lapse or fibrosis, emphysematous changes, etc. 
(3) Pleural abnormalities which included 
pleural thickening and free fluid. 
(4) Any other abnormal features not 
described by the above categories. 
Results 
In the 23 patients of ABPA whose CT scans were 
evaluated, there were 138 lobes available for 
study, as the lingula, for analysis purposes, was 
counted as a separate lobe. However, one patient 
who had previously undergone a left lower lobec- 
tomy for an aspergilloma, presented with collapse 
of the remaining two left lobes along with an 
associated ipsilateral pleural effusion (15), thus 
leaving a total of 135 lobes for study, comprising 
408 segments, which also included two extra 
subapical segments in two patients. 
BRONCHIAL ABNORMALITIES 
One more lobe had to be excluded while analys- 
ing bronchial abnormalities, due to the left 
upper lobe consolidation in one patient which 
left a total of 134 lobes with 406 segments. 
Central Bvonchiectasis 
Central bronchiectasis, as evidenced by ‘string of 
pearls’ (Plate 1) and ‘signet-ring’ (Plate 2) 
appearances, was a universal finding in all 23 
(100%) patients, and this involved 114 (85%) of 
134 lobes. Of these 114 lobes, 80 (70%) had CB 
with normal peripheral bronchi, while in 34 
(30%) lobes [in 17 (74%) patients] CB also 
extended to the periphery. The remaining 20 
(15%) lobes had normal bronchi. 
At the segmental level, of the total 406 seg- 
ments, 210 (52%) had CB, of which 165 (79%) 
had normal tapering bronchi peripherally, 
while in 45 (21%) lobes, CB extended to the 
periphery. The remaining 196 (48%) segments 
had normal bronchi. Supplemental 4-mm scans, 
performed in eight patients, gave a sharper 
picture of the bronchi and were helpful in 
assessment of 48 (12%) of the 406 segmental 
bronchi studied. 
Distribution According to Site 
The distribution of the 134 lobes available for 
study is summarized in Table 2. Of the 44 upper 
216 N.PANCHAL ET AL 
involved in nine (47%) lobes. On the left side, 
both segments were involved in 12 (67%) out of 
18 lingulas. Of the 45 lower lobes available for 
study, CB was detected in 38 (84%). The apical 
segment was the only segment affected in 16 
(42Oh) lower lobes, five on the right and 11 on the 
left side. 
Other Bronchial Abnormalities 
PLATE 1. Computed tomographic scan of Patient 1 
at the level of right middle lobe bronchus showing 
‘string of pearls’ appearances (arrows), involving 
both medial and lateral segments of the right 
middle lobe bronchus, inferior lingular bronchus 
and the apical segmental bronchus of the left lower 
lobe. 
Dilated and totally occluded bronchi as evi- 
denced by beaded tubular opacities (Plate 2) and 
dense circular opacities (Plate 3) were observed 
in 11 (48%) patients. Air-fluid levels within 
dilated bronchi were visualized in five (22%) 
patients. Bronchial wall thickening (Plate 3) was 
present in 10 (43%) patients, while parallel line 
opacities extending up to the periphery were seen 
in seven (30%) patients. 
PARENCHYMAL ABNORMALITIES 
lobes available for study, 39 (89%) had CB, of 
which 24 had CB with normal periphery, while 
15 lobes had CB which also extended to the 
periphery. Two or more segments were involved 
in 16 (73%) of the 22 right upper lobes (RULs) 
affected, compared to 10 (59%) of the 17 left 
upper lobes (LULs) affected. In the 19 right 
middle lobes (RMLs) affected, 16 (84%) medial 
segments had CB, while both segments were 
PLATE 2. Computed tomographic scan of Patient 1 
across upper lobes showing ‘signet-ring’ appear- 
ances (arrow) involving multiple segmental bronchi, 
a dense circular opacity (arrow) in the apical 
segmental bronchus of the right upper lobe and 
bronchial wall thickening (arrow head) in the 
dilated apicoposterior segmental bronchus of the 
left upper lobe. 
Consolidation (Plate 4) was seen in 10 (43%) 
patients. One patient had consolidation of the 
LUL, while consolidation was observed in iso- 
lated segments in nine patients (five RULs, one 
RML, one RLL, two LLLs). Non-homogeneous 
patchy consolidation was noted in 15 (67%) 
patients. Collapse was detected in four patients, 
three of whom had segmental collapse (one each 
in RUL, RML and LLL), while the patient (15) 
who had earlier undergone a left lower lobec- 
tomy presented with collapse of the remaining 
two left lobes (Plate 5). Parenchymal scarring of 
varying extent was present in 19 (83%) patients. 
Six cavities (Plate 4) were observed in three 
(13%) patients (two RULs, two LULs, one RML 
and one LLL). An emphysematous bullae was 
seen in one (4%) patient in LUL. 
PLEURAL ABNORMALITIES 
The pleura was involved in 10 (43%) of the 23 
patients. Ipsilateral pleural effusion was seen in 
the patient (15) who had earlier undergone left 
lower lobectomy, and had presented with col- 
lapse of the remaining two lobes (Plate 5). In 
nine other patients, parenchymal lesions 
extended up to the pleura. 
Distribution of Lesions According to #he Stage of Disease 
As mentioned earlier, all patients had central 
bronchiectasis. In the two patients classified as 
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TABLE 2. Lobar distribution of central bronchiectasis (CB) in the 23 patients with allergic 
bronchopulmonary aspergillosis 
Total 
lobes 
for 
study 
Normal 
lobes 
Lobes 
with 
CB 
Lobes with 
CB with 
normal 
periphery 
Lobes with 
CB with 
peripheral 
bronchiectasis 
RUL 23 1 22 (96%) 24 8 (36%) 
LUL 21” 4 17 (81%) 10 7 (41%) 
RML 23 4 19 (83%) 14 5 (26%) 
Lingula 22” 4 18 (82%) 11 7 (39%) 
RLL 23 3 20 (87%) 15 5 (25%) 
LLL 22* 4 18 (82%) 16 2 (11%) 
Totals 134 20 114 (85%) 80 34 (30%) 
*Four lobes excluded from study (one patient had LUL consolidation, and one patient 
who had left lower lobectomy presented with collapse of LUL and lingula). 
RUL, right upper lobe; LUL, left upper lobe; RML, right middle lobe; RLL, right lower 
lobe; LLL, left lower lobe. 
Stage I (Acute), one had lobar and the other had 
segmental consolidation. In the three patients 
classified as Stage II (Remission), apart from 
CB, collapse of RUL was detected in one 
patient. Of the largest group of 16 patients, 
categorized as Stage III (Exacerbation), 13 had 
either segmental or patchy consolidation, while 
three had evidence of collapse. This also 
PLATE 3. Computed tomographic scan of Patient 
12 across right lower lobe showing beaded tubular 
opacities (white arrows), bronchial wall thickening 
(arrow head) and parenchymal infiltrates in the pos- 
terior segment (black arrow). 
included two of the three patients with cavities. 
In the single patient in Stage IV (Corticosteroid- 
dependent asthma), extensive parenchymal scar- 
ring with fibrotic bands were seen. The only 
patient who was categorized as Stage V (Fibrotic 
lung) had extensive fibrocavitary disease 
associated with loss of volume. 
Discussion 
Central bronchiectasis with normal peripheral 
bronchi is, radiologically, the most striking 
feature of ABPA, and when present, it is 
PLATE 4. Computed tomographic scan of Patient 
17 across right upper lobe showing consolidation 
(black arrow) of the anterior segment and a cavity 
(C) in the posterior segment. 
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PLATE 5. Computed tomographic scan of Patient 
22 showing collapsed left lobe (L) along with associ- 
ated pleural effusion (F). 
diagnostic of the disease. However, CB may not 
be present in the early phase of the disease (4). 
Allergic bronchopulmonary aspergillosis is not 
infrequent in cystic fibrosis (CF), a disease in 
which CB is also seen but normal peripheral 
bronchi are not seen (4). 
Previously, the present authors have demon- 
strated that CT, compared to bronchography, 
has the potential of being the investigation of 
choice for the demonstration of CB in ABPA 
(9,lO). Although high-resolution CT (HRCT) is 
now the accepted technique of choice for the 
diagnosis of bronchiectasis, contiguous S-mm 
scans with supplemental 4-mm scans were per- 
formed in selected areas in eight patients. Con- 
tiguous scans were done to avoid missing any 
lesions, as bronchiectasis in ABPA is often small, 
localized and widely scattered. Very thin (2 mm) 
to medium (5 mm) contiguous sections would 
have increased the radiation dose to the patients, 
and the standard IO-mm sections do not give a 
sharp picture of bronchi, especially those which 
course horizontally, due to the partial volume- 
averaging effect (6,7). The study protocol thus 
enabled visualization of the bronchi continu- 
ously and clearly with minimal radiation to the 
patient. 
Currie et al. (11) were able to detect CB on CT 
in nine of the 10 patients, involving 31 (57%) of 
the 54 lobes, while Neeld et al. (5) detected CB in 
six of their eight patients, involving 19 (41%) of 
the 46 lobes. A similar study from India (12) in 
15 patients detected CB in 57 (63%) of the 90 
lobes studied, and Angus et al. (16) detected CB 
in 14 of their 17 patients involving 43 (42%) of 
the 102 lobes. However, none of these studies 
analysed CB at segmental level. The relatively 
higher occurrence of CB (85% lobes and 52% 
segments) in the present patients was most prob- 
ably due to the delay in diagnosis caused by the’ 
radiological similarity to pulmonary tuberculo- 
sis. This led to 19 (83%) patients receiving anti- 
tuberculosis therapy for long durations before 
presenting to the authors, during which time 
lung damage continued to occur relentlessly. 
Extension of CB to the periphery seen in 30% 
of the lobes and 21% of the segments had also 
been observed by others (5,11,12,16). Neeld et al. 
(5) and Angus et al. (16) also observed CB in 15 
and 6%, respectively, of their asthma patients 
with a positive skin test to A. fumigatus. It 
appears that CB may extend to the periphery in 
a small number of segments. Concurring with 
the views expressed recently by Angus et al. (16) 
the authors feel that CB with normal peripheral 
bronchi should continue to be regarded as the 
diagnostic feature of ABPA. 
As observed previously (5,11,12), the disease 
also predominantly affected the upper lobes, the 
right more than the left lobe. In contrast, ‘usual’ 
bronchiectasis is more commonly seen in the 
lower lobes, the left more than the right lobe 
(17). 
Involvement of the pleura, seen in 43% of the 
present patients, is a feature not commonly 
attributed to ABPA. This also included one 
patient who presented with collapse and associ- 
ated ipsilateral pleural effusion, which could 
possibly be due to increased negative intrapleu- 
ral pressure caused by collapse of the lung (15). 
Pleural thickening was also observed on CT by 
Angus et al. (16) in 14 (82%) of their 17 patients. 
Pleural involvement in ABPA is yet to receive 
recognition, but may not be of major clinical 
significance. 
In three of the 23 patients of the present study, 
co-existent AAS was also detected. Concomitant 
occurrence of ABPA and AAS is a rarity (18,19), 
but AAS should be excluded in patients with 
ABPA with nasal symptoms. 
Computed tomography of the thorax has 
already emerged as a safe, rapid, effective and 
acceptable alternative to bronchography for the 
demonstration of central bronchiectasis in 
ABPA (9,lO). This study suggests that CT can 
provide a sensitive method not only for the 
assessment of bronchial abnormalities, but also 
for parenchymal and especially pleural involve- 
ment, an aspect which is yet to be highlighted. 
Although CB can extent to the periphery in 
ABPA, demonstration of CB with normal 
peripheral bronchi which occurs in the majority 
of segments should continue to be regarded as a 
sine qua IZZOYI for the diagnosis of ABPA. The 
authors feel that in a patient in whom APBA is 
considered as a possible diagnosis, evaluation 
with CT of the thorax should constitute a part of 
the diagnostic work-up. 
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